Javascript required
Skip to content Skip to sidebar Skip to footer

Tp Link Archer C6 Ac1200 Review en Espaãƒâ±ol

Adjunct membership is for researchers employed past other institutions who interact with IDM Members to the extent that some of their ain staff and/or postgraduate students may work within the IDM; for iii-yr terms, which are renewable.


BARRY Iii, Dr Clifton
PhD, Department Chief and Senior Investigator, Tuberculosis Research Section (TRS), National Plant of Allergy and Infectious Diseases (NIAID) at the Usa National Institutes of Health (NIH).

Areas of interest span the basic sciences of chemical science, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery research.

email


Dark-brown, Prof Gordon
PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Heart for Medical Mycology at the University of Exeter and Manager of the AFGrica Unit of measurement at The University of Cape Town (UCT). Honorary Professor at UCT.

His primary research interests are C-type lectin receptors and their part in homeostasis and amnesty, with a particular focus on antifungal immunity.

email


GRAY, Prof Clive
Professor Emeritus of Immunology, Partition of Immunology, Department of Pathology, University of Greatcoat Town; Professor of Immunology in Molecular Biology and Human Genetics, Stellenbosch University, Cape Town; Offshoot Professor, Section of Immunology, Knuckles University, North Carolina, USA; Secretary-General, Federation of African Immunology Societies; Vice-Chair, Pedagogy Committee of the IUIS; Director of the Immunopaedia Foundation.

His inquiry interests revolve around investigating immune regulation and dysregulation in the context of HIV infection or exposure. He focuses on Allowed ontogeny in HIV exposed infants, placental investigations and pre-term nascence, and epithelial immunity in the foreskin. He has an active grouping inside the IDM and is based at Stellenbosch Academy where he directs the Reproductive Immunology Inquiry Consortium in Africa (RIRCA). He is the past Chair of Immunology at UCT and holder of several NIH and European-based grants.

email


Grey, Prof Glenda
MBBCH, FCP (Paeds) SA. Executive Director Perinatal HIV Enquiry Unit of measurement, Wits Wellness Consortium, University of Witwatersrand; Associate Professor, Department of Paediatrics, University of Witwatersrand, South Africa; HVTN Director of International Programmes; HVTN Co-Primary Investigator; Chair of the continuing committee on Health, ASSAF.

Her Research Unit of measurement is involved with clinical research, epidemiology and operational research, and is a treatment site for HIV infected adults and children. Her inquiry interests include HIV vaccine research, microbicide research and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in late phase clinical development. Her TB research includes examining new agents to prevent TB, TB prophylaxis and TB vaccine evaluation.

email


GROBUSCH, Prof Martin
Professor, Dr. Med. (M.D.), PhD, M.Sc. (Lond), DTM&H (Lond), FRCP (Lond). Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Full Professor and Chair of Tropical Medicine and Travel Medicine and Head, Heart of Tropical Medicine and Travel Medicine, Amsterdam Medical Eye, Academy of Amsterdam in kingdom of the netherlands.

He has been an author on over 150 manuscripts in the field of infectious diseases and has an all-encompassing track record in infectious diseases research and practice covering clinical, laboratory and epidemiological aspects.

email


LESLIE, Dr Al
Principal investigator Africa Health Inquiry Institute (AHRI), Durban, South Africa; Associate Professor, University of KwaZulu Natal, Durban, South Africa; Wellcome Trust senior Boyfriend, department of infection and immunity, University College London, UK.

He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can be observed from the blood. The research goal is to better understanding of the immunopathology of TB and HIV, using this information to aid in developing novel therapeutic approaches and diagnostic biomarkers.

email


LEWINSOHN , Prof Dave

MD, PhD, Professor and Vice Chair for Research, Department of Medicine, Director OHSU Eye for Global Kid Wellness Inquiry, Department of Pediatrics.

His inquiry has centered on understanding the mechanisms past which the human immune arrangement recognises the Mycobacterium tuberculosis (G.tb) infected prison cell. This research has focused largely on CD8+ T cells, with a focus on both those antigens that are recognised, and the means by which they are presented. His work has a strong translational component, asking if both classically and non-classically restricted T cells are associated with infection with G. tb, reflect immunological retentiveness, and are enriched at the site of infection.

email


LEWINSOHN, Prof Deborah

Doc, Professor, and Vice Chair for Research, Division Caput Infectious Disease, Wayne L. Tracy Professor of Infectious Disease, Section of Pediatrics, Assistant Director, OHSU Center for Global Kid Wellness Research.

Her enquiry focuses on understanding the function of the developing immune organisation on the susceptibility of young children to tuberculosis (TB) and understanding the part of innate and adaptively caused CD8+ T cells in host defense to TB. The translational significance of this research is centred on informing the evolution of novel vaccines and diagnostics for childhood TB.

email


MOORE, A/Prof Penny
South African Inquiry Chair in Viral Host Dynamics, Faculty of Wellness Sciences, University of Witwatersrand and National Establish for Infectious disease.

Her electric current research focuses on HIV broadly neutralising antibodies and their coaction with the evolving virus. Recent studies published in PloS Pathogens, Nature and Nature Medicine have highlighted the role of viral escape in creating new epitopes and immunotypes, thereby driving the evolution of neutralisation breadth, with implications for HIV vaccine pattern.

email


NICOL, Prof Marking
School of Biomedical Sciences, Division of Infection and Immunity, University of Western Australia; Professor in Microbiology.

Research interest in tuberculosis and in developing and testing point of care diagnostics suitable for the developing world.

email


REDD, Dr Andrew
PhD, Staff Scientist in International HIV and STD Section, National Institute of Allergy and Infectious Diseases at the US National Institutes of Health; Assistant Professor of Medicine at Johns Hopkins Academy.

His research is focused on better understanding HIV manual and disease dynamics with a special concentration on HIV superinfection, latent HIV infection, and the office of the virus in HIV+ organ transplantation.

email


WILKINSON, A/Prof Katalin
Main Research Scientist at The Francis Crick Constitute London; Honorary Associate Professor, Division of Infection and Amnesty, Academy Higher London; Honorary Associate Professor, Department of Medicine, University of Cape Town.

Her inquiry focuses on the immunology of HIV-associated tuberculosis (TB). More than specifically, the reconstitution of the immune response during antiretroviral treatment, in order to place correlates of protection (including immune mechanisms that atomic number 82 to reduced susceptibility to TB), and pathogenesis (such as the Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, TB-IRIS); the biosignature of the TB infection spectrum, from latent infection to active disease; preventing TB infection in HIV infected people more effectively; and the pathogenesis of tuberculous meningitis and pericarditis.

email

johnsonwhailee77.blogspot.com

Source: http://www.idm.uct.ac.za/Adjunct_Members